Open Orphan plc changes its name to hVIVO plc, learn more here.

Media Library

Categories:

Video Categories
  • Interview
  • Investors
  • Scientific
  • Corporate
  • Presentation
  • Podcast

12 Jun 2024

Dr Andrew Catchpole on Omicron BA.5 Characterisation Study

03 Jun 2024

hVIVO secures £2.5mln contract for Omicron characterisation study

03 Jun 2024

Hvivo Q&A: “this contract is important as it opens up new markets”

09 May 2024

WVC Washington: Interview with hVIVO's Dr Andrew Catchpole

09 Apr 2024

Hvivo results Q&A with CEO Mo Khan: “we are very confident we will get to £100m of revenue in 2028”

09 Apr 2024

hVIVO achieves record revenue and initiates dividend policy following successful year

13 Mar 2024

Yamin ‘Mo’ Khan, CEO of hVIVO, presents at the UK Investor Magazine Investor Conference at the London Stock Exchange

19 Feb 2024

hVIVO chairman Cathal Friel says he remains committed to hVIVO following share sale

30 Jan 2024

hVIVO PLC - Company Presentation

30 Jan 2024

hVIVO announces record financial performance for 2023; projects strong future growth

30 Jan 2024

Q&A with hVIVO’s Mo Khan: “£80 million is the highest starting order book in the history of the company"

02 Jan 2024

hVIVO secures £6.3 million challenge contract

28 Dec 2023

Ask the Experts: A Deep Dive into Human Challenge Trials

28 Dec 2023

Year in Review 2023

21 Dec 2023

hVIVO year in review: bigger and better

13 Dec 2023

hVIVO secures fresh contract to round out "wonderful" year

13 Dec 2023

Q&A: hVivo’s Mo Khan on the company’s latest mega-deal

25 Sep 2023

Master Investor Sector Focus: Healthcare

20 Sep 2023

hVIVO Canary Wharf Facilities - Adam French

13 Sep 2023

hVIVO PLC - Interim Results Presentation

12 Sep 2023

Q&A with hVIVO’s Mo Khan

12 Sep 2023

hVIVO has "the perfect opportunity" after strong first half

29 Aug 2023

Plans for a new larger state-of-the-art facility in Canary Wharf

29 Aug 2023

hVIVO announces move to "good facility at a very good price"

31 Jul 2023

Developing an Influenza B Human Challenge Model

26 Jul 2023

hVIVO plc – Trading update H1 2023

26 Jul 2023

hVIVO’s Mo Khan: “We have now got 100% contracted work this year to hit our revenue targets”

26 Jul 2023

hVIVO CEO reports on "very strong" H1 2023

25 Jul 2023

hVIVO’s Mo Khan: “the industry is really waking up to the value of human challenge models"

25 Jul 2023

hVIVO signs second bespoke human challenge model contract in as many months

10 Jul 2023

hVIVO targeting the nasty virus no one has heard of

29 Jun 2023

hVIVO to Develop hMPV Human Challenge Model

28 Jun 2023

hVIVO to develop first commercial hMPV human challenge model

15 May 2023

Topra Webinar - Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 Vaccines

15 May 2023

Tom Scott: The people who get paid to get sick

25 Apr 2023

Full Year Results 2022

25 Apr 2023

'Mo' Khan of Hvivo: 2022 was a transformative and order book gives strong visibility into H1 2024

25 Apr 2023

hVIVO reveals audited results for "transformational" 2022

14 Apr 2023

hVIVO at World Vaccine Congress Washington 2023

02 Mar 2023

hVIVO’s Andrew Catchpole Talks Human Challenge Trials, From COVID-19 to Malaria

06 Feb 2023

hVIVO Asian growth strategy bearing fruit with second 2023 contract win

25 Jan 2023

hVIVO PLC - Investor Presentation

15 Jan 2023

hVIVO's Mo Khan on the company’s breakthrough year

15 Jan 2023

hVIVO announces "record results" for 2022

05 Jan 2023

hVIVO CEO Mo Khan discusses the company's Asia Pacific breakthrough

04 Jan 2023

hVIVO contract the fruit of increasing Asian focus

03 Jan 2023

Year in Review 2022 - hVIVO Group

10 Nov 2022

hVIVO hails growing contract values after winning £13.6mln RSV challenge trial deal

02 Nov 2022

Capital Markets Day 2022

08 Sep 2022

OPEN ORPHAN PLC - 2022 Interim Results - Investor presentation

08 Sep 2022

Open Orphan's CEO talks through name change and a first half 'full of highlights'

05 Aug 2022

£6.2m Influenza human challenge study contract - BRR Media

04 Aug 2022

Open Orphan subsidiary hVIVO wins £6.2m Influenza human challenge study contract with US customer

01 Jul 2022

Open Orphan and Vaxart are preparing a world-first human challenge model for omicron oral vaccine

15 Jun 2022

LSX World Congress 2022

14 Jun 2022

hVIVO’s £7.2m RSV Human Challenge Model Contract

07 Jun 2022

Open Orphan’s Yamin Khan talks through its ‘excellent’ results

01 Jun 2022

Open Orphan racks up another ‘first’ with £14.7mln full-service flu contract

19 May 2022

Chief Scientific Officer on Influenza Challenge Study contract Win

09 Mar 2022

London South East Presentation March 2022

08 Mar 2022

Open Orphan sticks to 2021 earnings guidance as it announces an expansion of its facilities

08 Mar 2022

Volunteer Recruitment & Laboratory Facilities Expansion – Robin Rogiers & BRR Media

24 Feb 2022

CEO Appointment at Open Orphan

24 Feb 2022

Open Orphan announce Yamin ‘Mo’ Khan as new CEO

17 Feb 2022

hVIVO hail data on phase 2a study published in New England Journal of Medicine

14 Feb 2022

Open Orphan subsidiary hVIVO launch of STRiVE to ‘find out what people are actually suffering from’

14 Feb 2022

Adrian Wildfire on hVIVO STRiVE Project

02 Feb 2022

Open Orphan’s Cathal Friel presents results from world’s first COVID-19 characterisation study

02 Feb 2022

CSO Andrew Catchpole on the world’s first COVID-19 Characterisation Study

02 Feb 2022

Open Orphan present ‘invaluable’ key findings of world’s first COVID-19 characterisation study

24 Jan 2022

Executive Chairman Cathal Friel on The world’s first COVID-19 Characterisation Study

24 Jan 2022

hVIVO Malaria Challenge Agent

20 Jan 2022

Cathal Friel on Malaria Human Challenge Agent

21 Dec 2021

Open Orphan hail £5m contract for new flu jab challenge study

24 Aug 2021

Cathal Friel and BRR Media Discuss £8.1m Asthma Human Challenge Study Contract Win

20 Jul 2021

Open Orphan announce ‘substantial contract wins’ with an existing client and UK government

07 Jun 2021

FluCamp Hotel Quarantine Facility – Bedroom Tour

09 Apr 2021

Open Orphan: Global Leader in Human Challenge Vaccine Development | Executive Chairman Cathal Friel

16 Dec 2020

hVIVO secure MHRA approval to start Codagenix COVID-19 Phase I Vaccine Trial

16 Dec 2020

Shares Investor Evening with Cathal Friel December 2020

07 Dec 2020

Open Orphan 2020 Year in Review

20 Nov 2020

COVID-19: UK scientists to infect volunteers with coronavirus in world first vaccine trial

20 Oct 2020

Young people to be deliberately exposed to Covid-19 to speed up vaccine development

20 Oct 2020

Market Coverage: Tuesday October 20 Yahoo Finance

06 Oct 2020

Shares Magazine Investor Evening October 2020

06 Oct 2020

Open Orphan Dual Business Firing on All Four Cylinders

01 Oct 2020

Open Orphan Interim Results Interview 2020

10 Aug 2020

Interview with Proactive Investors following £4M contract with Top 3 Global Pharma company

08 Jun 2020

Coronavirus: I took a COVID-19 antibody test to see if I’d had coronavirus without realising it

11 May 2015

FluCamp – what it is like to participate in a clinical trial

15 Sep 2014

hVIVO on BBC1 2014
chevron-downcross-circle